An autism-linked mutation disables phosphorylation control of UBE3A.
Internet-based, randomized, controlled trial of omega-3 fatty acids for hyperactivity in autism.
Transferable neuronal mini-cultures to accelerate screening in primary and induced pluripotent stem cell-derived neurons.
Inactivating mutations in MFSD2A required for omega-3 fatty acid transport in brain, cause a lethal microcephaly syndrome.
Maternal UBE3A loss disrupts sleep homeostasis but leaves circadian rhythmicity largely intact.
Emergence of a Homo sapiens-specific gene family and chromosome 16p11.2 CNV susceptibility.
Dissociation of locomotor and cerebellar deficits in a murine Angelman syndrome model.
Comprehensive analysis of the 16p11.2 deletion and null CNTNAP2 mouse models of autism spectrum disorder.
Impaired amino acid transport at the blood brain barrier is a cause of autism spectrum disorder.
Layer specific and general requirements for ERK/MAPK signaling in the developing neocortex.
- Previous Page
- Viewing
- Next Page